Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

New antifungals disclosed by Schering-Plough

Dec. 31, 1997

Lilly develops compounds for the common cold; selects development candidate

Dec. 30, 1997

Aronex/Ferrer seek approval of Nyotran in Spain

Dec. 29, 1997

Lidak submits NDA for Lidakol

Dec. 29, 1997

SS Pharm. patents new antifungal agents

Dec. 29, 1997

BLA filed for palivizumab

Dec. 24, 1997

New antibacterial agent discovered by Sankyo

Dec. 24, 1997

RD4-6250: a potential new treatment for HCV

Dec. 24, 1997

New launches for Abelcet; The Liposome Co./Wyeth-Ayerst partnership broadened

Dec. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...